The DOI matches its Crossref record; 59 of the 60 references it cites were found in a registry or an index.
Vasopressinergic Regulation of the Hypothalamic Pituitary Adrenal Axis and Stress Adaptation
Open accessAbstract
Vasopressin (VP) stimulates pituitary ACTH secretion through interaction with receptors of the V1b subtype (V1bR, V3R), located in the plasma membrane of the pituitary corticotroph, mainly by potentiating the stimulatory effects of corticotropin releasing hormone (CRH). Chronic stress paradigms associated with corticotroph hyperresponsiveness lead to preferential expression of hypothalamic VP over CRH and upregulation of pituitary V1bR, suggesting an important role for VP during adaptation of the hypothalamic-pituitary-adrenal (HPA) axis to stress. Vasopressinergic regulation of ACTH secretion depends on the number of V1bRs as well as coupling of the receptor to phospholipase C (PLC) in the pituitary. Regulation of V1bR gene transcription may involve a number of regulatory elements in the promoter region, of which a GAGA box was shown to be essential. Although V1bR gene transcription is necessary to maintain V1bR mRNA levels, the lack of correlation between VP binding and V1bR mRNA suggests that regulation of mRNA translation is a major regulatory step of the number of V1bRs. V1bR translation appears to be under tonic inhibition by upstream minicistrons and positive regulation through protein kinase C (PKC) activation of an internal ribosome entry site (IRES) in the 5' untranslated region (5'UTR) of the mRNA. The data provide mechanisms by which regulation of hypothalamic VP and pituitary V1bR content contribute to controlling HPA axis activity during chronic stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Namely, it has been indicated that both CRH and AVP act on their own receptors (28–32) on corticotrope cells in anterior pituitary to stimulate adrenocorticotropic hormone (ACTH) production and release with different (26, 33–41) or even similar potencies (42).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [32]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In essence, CRH and AVP are both required as stimulatory inputs to corticotrope cells for a complete ACTH response in physiologically normal as well as in various stressful conditions (32, 38, 48–51).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Morgan, J., & Curran, T. (1991) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.14.030191.002225 · Cited by 2,689 · cited 3×
“…leading to the production of intermediate early genes or transcription factors capable to interact with glucocorticoid receptors and to modify their activity at the responsive element in the gene promoter (Diamond et al., 1990; Morgan and Curran, 1991; Webster and Cidlowski, 1999).”
BackgroundNeurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis
Herman, J. P., & Cullinan, W. E. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)10069-2 · Cited by 2,270 · cited 1×
“Glucocorticoids are likely to act at multiple sites, inhibiting VP secretion by direct actions on the parvocellular neuron, and indirectly by modifying the activity of neural pathways to the parvocellular neuron such as GABAergic and glutamatergic afferents (Herman and Cullinan, 1997; Kiss, 1998).”
An analysis of vertebrate mRNA sequences: intimations of translational control.
Kozak, M. (1991) · The Journal of Cell Biology · doi:10.1083/jcb.115.4.887 · Cited by 1,631 · cited 1×
“Upstream ORFs have been described in yeast and several eukaryotic mRNAs and are recognized to reduce the ability of ribosomes to linearly scan the V1b 50UTR mRNA according to conventional scanning models and therefore to slow translation (Kozak, 1991).”
BackgroundDiamond, M. I., Miner, J. N., Yoshinaga, S. K., & Yamamoto, K. R. (1990) · Science · doi:10.1126/science.2119054 · Cited by 1,274 · cited 2×
“…leading to the production of intermediate early genes or transcription factors capable to interact with glucocorticoid receptors and to modify their activity at the responsive element in the gene promoter (Diamond et al., 1990; Morgan and Curran, 1991; Webster and Cidlowski, 1999).”
BackgroundCorticotropin releasing activity of the new CRF is potentiated several times by vasopressin
Gillies, G. E., Linton, E. A., & Lowry, P. J. (1982) · Nature · doi:10.1038/299355a0 · Cited by 965 · cited 2×
“In humans and rodents, VP alone is a weak stimulus of ACTH secretion, but through its interaction with CRH it contributes to maintaining corticotroph responsiveness in spite of elevated glucocorticoid levels during chronic stress (Gilles et al., 1982; Antoni, 1993; Aguilera, 1994).”
BackgroundDi, S., Malcher‐Lopes, R., Halmos, K. C., & Tasker, J. G. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-04850.2003 · Cited by 820 · cited 1×
“Recent studies show that glucocorticoids induce the release of endogenous cannabinoids in the PVN, which can mediate rapid indirect, non-genomic glucocorticoid feedback in the parvocellular neuron (Di et al., 2003).”
BackgroundRegulation of ACTH Secretion: Variations on a Theme of B
DALLMAN, M. F., AKANA, S. F., CASCIO, C. S., DARLINGTON, D. N., JACOBSON, L., & LEVIN, N. (1987) · Proceedings of the 1986 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571143-2.50010-1 · Cited by 655 · cited 3×
“Circulating glucocorticoids exert a negative feedback effect on the expression of CRH and VP in parvocellular PVN neurons (Dallman et al., 1987), but there is evidence of preferential inhibition of VP compared with CRH expression (Ma et al.”
BackgroundVasopressinergic control of pituitary adrenocorticotropin secretion comes of age
Antoni, F. A. (1993) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1993.1004 · Cited by 636 · cited 4×
“external zone of the median eminence (Antoni, 1993).”
BackgroundInfluentialRegulation of pituitary ACTH secretion during chronic stress
Aguilera, G. (1994) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1994.1013 · Cited by 557 · cited 11×
“Also, VP markedly potentiates the stimulatory effects of corticotropin releasing hormone (CRH) on ACTH secretion (Gilles et al., 1982; DeGoeij et al., 1991; Aguilera, 1994).”
BackgroundInfluentialHormonal regulation of peptide receptors and target cell responses
Catt, K. J., Harwood, J. P., Aguilera, G., & Dufau, M. L. (1979) · Nature · doi:10.1038/280109a0 · Cited by 531 · cited 1×
“In addition to receptor synthesis, the number of active VP receptors could be influenced by ligand binding, leading to receptor desensitization and internalization as occurs with other G-protein coupled receptors (Catt et al., 1979; Ferguson and Caron, 1998).”
Background
Research works printed but not linked: 10
- Carvallo P., 1989, Endocrinol, 3, 1935
- Dallman M.F., 1987, Recent Prog. Horm. Res., 42, 113
- DeGoeij D.C.E., 1991, Neuroendocrinology, 53, 150, 10.1159/000125712 · DOI · Paper page
- Levin N., 1991, Front. Neuroendocrinol., 12, 1
- McCann S.M., 1954, Proc. Natl Acad. Sci. USA, 87, 318
- Mori Y., 1996, Role of upstream AUG triplets, Hypertension, 28, 810
- Rabadan-Diehl C., 2002, Neuroscience, Orlando FL, abst
- Rabadan-Diehl C., 2003, Endocrinol, 17, 1959
- Seibold A., 1992, Am. J. Hum. Genet., 51, 1078
- Sonnenberg, N. (1996) In: Hershey, J.W.B., Mathews, M.B. and Sonenberg, N., eds, Translational Control (Cold Spring Harbor Lab. Press, Plainview, NY), pp 245–269.
Cited by
Sorted by citations
Dumais, K. M., & Veenema, A. H. (2016) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2015.04.003 · Cited by 520
“As such, VP is part of the hypothalamic-pituitaryadrenal (HPA) axis, a system involved in the neuroendocrine stress response (Herman, 1995; Volpi et al., 2004).”
BackgroundRole of glucocorticoid negative feedback in the regulation of HPA axis pulsatility
Gjerstad, J. K., Lightman, S. L., & Spiga, F. (2018) · Stress · doi:10.1080/10253890.2018.1470238 · Cited by 437
“Although the role of vasopressin in regulating ACTH secretion in responses to stress is well known (Volpi et al., 2004), current evidence suggests that vasopressin does not regulate basal HPA axis activity.”
BackgroundYoung, W. S., Li, J., Wersinger, S. R., & Palkovits, M. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.08.040 · Cited by 222
“…the role of the Avpr1b in regulating adrenocorticotropin hormone from the anterior pituitary in response to stress, especially chronic, has been extensively studied (for reviews, see (Engelmann et al., 2004; Volpi et al., 2004)) ever since the receptor was first described (Antoni et al., 1984).”
BackgroundResultEpigenetics of stress adaptations in the brain
Stankiewicz, A. M., Swiergiel, A. H., & Lisowski, P. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.07.003 · Cited by 220
The stress hormone copeptin: a new prognostic biomarker in acute illness
Christ‐Crain, M. (2010) · Swiss Medical Weekly · doi:10.4414/smw.2010.13101 · Cited by 216
Metadata
- Authors
- Volpi, S., Rabadan-Diehl, C., & Aguilera, G.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Aguilera, Greti
- ORCID
- Volpi, Simona
- Venue
- Stress
- Publisher
- Informa UK Limited
- Published
- 2004-06
- Volume
- 7
- Issue
- 2
- Pages
- 75-83
- ISSN
- 1025-3890 (ISSN-L)
- 1607-8888
- OpenAlex
- W2094450224
- Cited by
- 136
- References
- 60
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 10 · 2021: 5 · 2020: 3 · 2019: 4 · 2018: 7 · 2017: 6 · 2016: 4 · 2015: 5 · 2014: 6 · 2013: 9 · 2012: 3
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- public-domain
- Locations
- Stress (publishedVersion, public-domain)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- vasopressin, V1b receptor, hypothalamic-pituitary-adrenal axis, ACTH secretion, corticotropin-releasing factor, chronic stress, stress adaptation, phospholipase C signaling, mRNA translation regulation, protein kinase C, internal ribosome entry site, 5' untranslated region
- MeSH terms
- Adaptation, Physiological, Animals, Humans, Hypothalamo-Hypophyseal System, Pituitary-Adrenal System, Stress, Physiological, Vasopressins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review